Overexpression and amplification of c-myc in the Syrian hamster kidney during estrogen carcinogenesis: A probable critical role in neoplastic transformation
Jj. Li et al., Overexpression and amplification of c-myc in the Syrian hamster kidney during estrogen carcinogenesis: A probable critical role in neoplastic transformation, CANCER RES, 59(10), 1999, pp. 2340-2346
An estrogen receptor-driven, multistep process for estrogen carcinogenesis
in the Syrian hamster kidney is proposed. Because in this species the repro
ductive and urogenital tracts arise from the same embryonic germinal ridge,
it is evident that the kidney has carried over genes that are responsive t
o estrogens, Using in situ hybridization, overexpression of early estrogen-
response genes, i.e., c-myc and c-fos, has been shown to be localized prefe
rentially in early renal tumor foci after 3.5-4.0 months of estrogen treatm
ent. This event coincides with an increased number of S-phase proliferating
cell nuclear antigen-labeled cells in these tumor foci, along with a rapid
rise in aneuploid frequency in the kidney. Western blot analyses of c-MYC
and c-FOS protein products support the overexpression of these genes, Ampli
fication of c-myc, 2.4-3.6-fold, but not of c-fos, was detected in 67% of t
he primary renal tumors examined, by Southern blot analyses. Consistent chr
omosomal gains, common to both diethylstilbestrol- and estradiol-induced re
nal neoplasms, were observed in chromosomes 1, 2, 3, (6), 11, (13), 16, 20,
and 21 (chromosome number alterations are indicated in parentheses). Using
fluorescence in situ hybridization, the c-myc gene was localized to hamste
r chromosome 6qb, Chromosome 6 exhibited a high frequency of trisomies and
tetrasomies in the kidney after 5.0 months of estrogen treatment and in pri
mary renal tumors. The data presented indicate that estrogen-induced genomi
c instability may be a key element in carcinogenic processes induced by est
rogens.